Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 59

1.

Chorio-retinal toxoplasmosis: treatment outcomes, lesion evolution and long-term follow-up in a single tertiary center.

Vishnevskia-Dai V, Achiron A, Buhbut O, Berar OV, Musika AA, Elyashiv SM, Hecht I.

Int Ophthalmol. 2019 Dec 2. doi: 10.1007/s10792-019-01242-1. [Epub ahead of print]

PMID:
31792847
2.

Re-Treatment by Flap Relift Versus Surface Ablation After Myopic Laser In Situ Keratomileusis.

Hecht I, Mimouni M, Rabina G, Kaiserman I.

Cornea. 2019 Oct 24. doi: 10.1097/ICO.0000000000002189. [Epub ahead of print]

PMID:
31658171
3.

Long-Term Follow-up of Pseudotumor Cerebri Syndrome in Prepubertal Children, Adolescents, and Adults.

Hilely A, Hecht I, Goldenberg-Cohen N, Leiba H.

Pediatr Neurol. 2019 Dec;101:57-63. doi: 10.1016/j.pediatrneurol.2019.04.018. Epub 2019 Apr 27.

PMID:
31604646
4.

B-cell related biomarkers associated with severity of the first demyelinating event of acute optic neuritis.

Achiron A, Hecht I, Abayev L, Naftali Ben Haim L, Feldman A, Gurevich M.

Eye (Lond). 2019 Oct 10. doi: 10.1038/s41433-019-0614-9. [Epub ahead of print]

PMID:
31601977
5.

Traumatic Cataracts in Children, Long-Term Follow-up in an Israeli Population: A Retrospective Study.

Hilely A, Leiba H, Achiron A, Hecht I, Parness-Yossifon R.

Isr Med Assoc J. 2019 Sep;21(9):599-602.

6.

REDUCTION OF POSTINTRAVITREAL INJECTION PAIN USING ICE: An Open-Label Interventional Randomized Controlled Trial.

Yahalomi T, Hecht I, Lagstein O, Nemet A, Peʼer L, Hadad F, Keren-Yaar A, Kassem R, Burgansky-Eliash Z, Bar A, Achiron A.

Retina. 2019 Jul 10. doi: 10.1097/IAE.0000000000002608. [Epub ahead of print]

PMID:
31305506
7.

Development of "Predict ME," an online classifier to aid in differentiating diabetic macular edema from pseudophakic macular edema.

Hecht I, Achiron R, Bar A, Munk MR, Huf W, Burgansky-Eliash Z, Achiron A.

Eur J Ophthalmol. 2019 Jul 10:1120672119865355. doi: 10.1177/1120672119865355. [Epub ahead of print]

PMID:
31290338
8.

Refractive surgery in the late adulthood and adolescent age groups.

Hecht I, Achiron A, Ben Haim L, Sorin V, Mimouni M, Kaiserman I.

Graefes Arch Clin Exp Ophthalmol. 2019 Sep;257(9):2057-2063. doi: 10.1007/s00417-019-04396-x. Epub 2019 Jun 19.

PMID:
31218400
9.

Permethrin Cream for the Treatment of Demodex Blepharitis.

Hecht I, Melzer-Golik A, Sadi Szyper N, Kaiserman I.

Cornea. 2019 Dec;38(12):1513-1518. doi: 10.1097/ICO.0000000000002013.

PMID:
31169611
10.

Efficacy and safety of the ab interno gelatin stent in severe pseudoexfoliation glaucoma compared to non-pseudoexfoliation glaucoma at 6 months.

Dar N, Sharon T, Hecht I, Kalev-Landoy M, Burgansky-Eliash Z.

Eur J Ophthalmol. 2019 May 10:1120672119848277. doi: 10.1177/1120672119848277. [Epub ahead of print]

PMID:
31072182
11.

Sulfur Hexafluoride (SF6) versus Perfluoropropane (C3F8) in the Intraoperative Management of Macular Holes: A Systematic Review and Meta-Analysis.

Hecht I, Mimouni M, Blumenthal EZ, Barak Y.

J Ophthalmol. 2019 Mar 12;2019:1820850. doi: 10.1155/2019/1820850. eCollection 2019. Review.

12.

Very late-onset flap margin corneal ulcer following laser in situ keratomileusis.

Rabina G, Azem N, Mimouni M, Hecht I, Varssano D.

Int Ophthalmol. 2019 Nov;39(11):2533-2538. doi: 10.1007/s10792-019-01100-0. Epub 2019 Apr 13.

PMID:
30982142
13.

Peak Occurrence of Retinal Detachment following Cataract Surgery: A Systematic Review and Pooled Analysis with Internal Validation.

Kassem R, Greenwald Y, Achiron A, Hecht I, Man V, Ben Haim L, Bukelman A.

J Ophthalmol. 2018 Nov 22;2018:9206418. doi: 10.1155/2018/9206418. eCollection 2018.

14.

The effect of sildenafil on retinal blood velocity in healthy subjects.

Achiron A, Hecht I, Juza C, Barak A, Burgansky-Eliash Z.

Eye Vis (Lond). 2018 Dec 5;5:30. doi: 10.1186/s40662-018-0125-y. eCollection 2018.

15.

OPTICAL COHERENCE TOMOGRAPHY BIOMARKERS TO DISTINGUISH DIABETIC MACULAR EDEMA FROM PSEUDOPHAKIC CYSTOID MACULAR EDEMA USING MACHINE LEARNING ALGORITHMS.

Hecht I, Bar A, Rokach L, Noy Achiron R, Munk MR, Huf W, Burgansky-Eliash Z, Achiron A.

Retina. 2019 Dec;39(12):2283-2291. doi: 10.1097/IAE.0000000000002342.

PMID:
30312254
16.

Frequency, comprehension and attitudes of physicians towards abbreviations in the medical record.

Hamiel U, Hecht I, Nemet A, Pe'er L, Man V, Hilely A, Achiron A.

Postgrad Med J. 2018 May;94(1111):254-258. doi: 10.1136/postgradmedj-2017-135515. Epub 2018 Mar 14.

PMID:
29540451
17.

Reduction of intraocular pressure after bariatric surgery.

Burgansky-Eliash Z, Achiron A, Hecht I, Shimonov M.

Acta Ophthalmol. 2018 Aug;96(5):e592-e595. doi: 10.1111/aos.13722. Epub 2018 Feb 28.

18.

ILDR2 Is a Novel B7-like Protein That Negatively Regulates T Cell Responses.

Hecht I, Toporik A, Podojil JR, Vaknin I, Cojocaru G, Oren A, Aizman E, Liang SC, Leung L, Dicken Y, Novik A, Marbach-Bar N, Elmesmari A, Tange C, Gilmour A, McIntyre D, Kurowska-Stolarska M, McNamee K, Leitner J, Greenwald S, Dassa L, Levine Z, Steinberger P, Williams RO, Miller SD, McInnes IB, Neria E, Rotman G.

J Immunol. 2018 Mar 15;200(6):2025-2037. doi: 10.4049/jimmunol.1700325. Epub 2018 Feb 5.

19.

ILDR2-Fc Is a Novel Regulator of Immune Homeostasis and Inducer of Antigen-Specific Immune Tolerance.

Podojil JR, Hecht I, Chiang MY, Vaknin I, Barbiro I, Novik A, Neria E, Rotman G, Miller SD.

J Immunol. 2018 Mar 15;200(6):2013-2024. doi: 10.4049/jimmunol.1700326. Epub 2018 Feb 5.

20.

Retinal layers thickness changes following epiretinal membrane surgery.

Hecht I, Yeshurun I, Bartov E, Bar A, Burgansky-Eliash Z, Achiron A.

Eye (Lond). 2018 Mar;32(3):555-562. doi: 10.1038/eye.2017.233. Epub 2017 Nov 10.

21.

Glycemic Control and Quality of Life Following Cataract Surgery in Patients with Type 2 Diabetes and without Maculopathy.

Bar-Oz D, Hecht I, Achiron A, Midlij M, Man V, Bar Dayan Y, Burgansky-Eliash Z.

Curr Eye Res. 2018 Jan;43(1):96-101. doi: 10.1080/02713683.2017.1383443. Epub 2017 Nov 7.

PMID:
29111818
22.

Treatment of retinal artery occlusion using transluminal Nd:YAG laser: a systematic review and meta-analysis.

Man V, Hecht I, Talitman M, Hilely A, Midlij M, Burgansky-Eliash Z, Achiron A.

Graefes Arch Clin Exp Ophthalmol. 2017 Oct;255(10):1869-1877. doi: 10.1007/s00417-017-3777-8. Epub 2017 Aug 19. Review.

PMID:
28823062
23.

Blood pressure dynamics during exercise rehabilitation in heart failure patients.

Hecht I, Arad M, Freimark D, Klempfner R.

Eur J Prev Cardiol. 2017 May;24(8):818-824. doi: 10.1177/2047487317690951. Epub 2017 Feb 7.

PMID:
28169556
24.

Modifiable factors in the management of glaucoma: a systematic review of current evidence.

Hecht I, Achiron A, Man V, Burgansky-Eliash Z.

Graefes Arch Clin Exp Ophthalmol. 2017 Apr;255(4):789-796. doi: 10.1007/s00417-016-3518-4. Epub 2016 Oct 14. Review.

PMID:
27743157
25.

diskImageR: quantification of resistance and tolerance to antimicrobial drugs using disk diffusion assays.

Gerstein AC, Rosenberg A, Hecht I, Berman J.

Microbiology. 2016 Jul;162(7):1059-1068. doi: 10.1099/mic.0.000295. Epub 2016 Apr 27.

26.

The motility-proliferation-metabolism interplay during metastatic invasion.

Hecht I, Natan S, Zaritsky A, Levine H, Tsarfaty I, Ben-Jacob E.

Sci Rep. 2015 Sep 4;5:13538. doi: 10.1038/srep13538.

27.

Erratum: Tumor Invasion Optimization by Mesenchymal-Amoeboid Heterogeneity.

Hecht I, Bar-El Y, Balmer F, Natan S, Tsarfaty I, Schweitzer F, Ben-Jacob E.

Sci Rep. 2015 Jul 30;5:12121. doi: 10.1038/srep12121. No abstract available.

28.

Tumor invasion optimization by mesenchymal-amoeboid heterogeneity.

Hecht I, Bar-El Y, Balmer F, Natan S, Tsarfaty I, Schweitzer F, Ben-Jacob E.

Sci Rep. 2015 May 27;5:10622. doi: 10.1038/srep10622. Erratum in: Sci Rep. 2015;5:12121.

29.

Propagating waves of directionality and coordination orchestrate collective cell migration.

Zaritsky A, Kaplan D, Hecht I, Natan S, Wolf L, Gov NS, Ben-Jacob E, Tsarfaty I.

PLoS Comput Biol. 2014 Jul 24;10(7):e1003747. doi: 10.1371/journal.pcbi.1003747. eCollection 2014 Jul.

30.

Cell motility dynamics: a novel segmentation algorithm to quantify multi-cellular bright field microscopy images.

Zaritsky A, Natan S, Horev J, Hecht I, Wolf L, Ben-Jacob E, Tsarfaty I.

PLoS One. 2011;6(11):e27593. doi: 10.1371/journal.pone.0027593. Epub 2011 Nov 9.

31.

"Self-assisted" amoeboid navigation in complex environments.

Hecht I, Levine H, Rappel WJ, Ben-Jacob E.

PLoS One. 2011;6(8):e21955. doi: 10.1371/journal.pone.0021955. Epub 2011 Aug 4.

32.

Activated membrane patches guide chemotactic cell motility.

Hecht I, Skoge ML, Charest PG, Ben-Jacob E, Firtel RA, Loomis WF, Levine H, Rappel WJ.

PLoS Comput Biol. 2011 Jun;7(6):e1002044. doi: 10.1371/journal.pcbi.1002044. Epub 2011 Jun 30.

33.

Transient localized patterns in noise-driven reaction-diffusion systems.

Hecht I, Kessler DA, Levine H.

Phys Rev Lett. 2010 Apr 16;104(15):158301. Epub 2010 Apr 14.

34.

Organization of the autoantibody repertoire in healthy newborns and adults revealed by system level informatics of antigen microarray data.

Madi A, Hecht I, Bransburg-Zabary S, Merbl Y, Pick A, Zucker-Toledano M, Quintana FJ, Tauber AI, Cohen IR, Ben-Jacob E.

Proc Natl Acad Sci U S A. 2009 Aug 25;106(34):14484-9. doi: 10.1073/pnas.0901528106. Epub 2009 Aug 10.

35.

Determining the scale of the Bicoid morphogen gradient.

Hecht I, Rappel WJ, Levine H.

Proc Natl Acad Sci U S A. 2009 Feb 10;106(6):1710-5. doi: 10.1073/pnas.0807655106. Epub 2009 Feb 3.

36.

A novel peptide agonist of formyl-peptide receptor-like 1 (ALX) displays anti-inflammatory and cardioprotective effects.

Hecht I, Rong J, Sampaio AL, Hermesh C, Rutledge C, Shemesh R, Toporik A, Beiman M, Dassa L, Niv H, Cojocaru G, Zauberman A, Rotman G, Perretti M, Vinten-Johansen J, Cohen Y.

J Pharmacol Exp Ther. 2009 Feb;328(2):426-34. doi: 10.1124/jpet.108.145821. Epub 2008 Nov 20.

PMID:
19023040
37.

Discovery and validation of novel peptide agonists for G-protein-coupled receptors.

Shemesh R, Toporik A, Levine Z, Hecht I, Rotman G, Wool A, Dahary D, Gofer E, Kliger Y, Soffer MA, Rosenberg A, Eshel D, Cohen Y.

J Biol Chem. 2008 Dec 12;283(50):34643-9. doi: 10.1074/jbc.M805181200. Epub 2008 Oct 9.

38.

Correlated phenotypic transitions to competence in bacterial colonies.

Hecht I, Ben-Jacob E, Levine H.

Phys Rev E Stat Nonlin Soft Matter Phys. 2007 Oct;76(4 Pt 1):040901. Epub 2007 Oct 2.

PMID:
17994927
39.

Perturbation analysis for competing reactions with initially separated components.

Hecht I, Taitelbaum H.

Phys Rev E Stat Nonlin Soft Matter Phys. 2006 Jul;74(1 Pt 1):012101. Epub 2006 Jul 10.

PMID:
16907140
40.

Reaction-diffusion front width anomalies in disordered media.

Hecht I, Moran Y, Taitelbaum H.

Phys Rev E Stat Nonlin Soft Matter Phys. 2006 May;73(5 Pt 1):051109. Epub 2006 May 24.

PMID:
16802920
41.

Halofuginone inhibits NF-kappaB and p38 MAPK in activated T cells.

Leiba M, Cahalon L, Shimoni A, Lider O, Zanin-Zhorov A, Hecht I, Sela U, Vlodavsky I, Nagler A.

J Leukoc Biol. 2006 Aug;80(2):399-406. Epub 2006 Jun 12.

PMID:
16769768
42.

Interface roughening dynamics: temporal width fluctuations and the correlation length.

Be'er A, Hecht I, Taitelbaum H.

Phys Rev E Stat Nonlin Soft Matter Phys. 2005 Sep;72(3 Pt 1):031606. Epub 2005 Sep 22.

PMID:
16241453
43.

Roughness and growth in a continuous fluid invasion model.

Hecht I, Taitelbaum H.

Phys Rev E Stat Nonlin Soft Matter Phys. 2004 Oct;70(4 Pt 2):046307. Epub 2004 Oct 21.

PMID:
15600519
44.

Allicin inhibits SDF-1alpha-induced T cell interactions with fibronectin and endothelial cells by down-regulating cytoskeleton rearrangement, Pyk-2 phosphorylation and VLA-4 expression.

Sela U, Ganor S, Hecht I, Brill A, Miron T, Rabinkov A, Wilchek M, Mirelman D, Lider O, Hershkoviz R.

Immunology. 2004 Apr;111(4):391-9.

45.

Heparin-disaccharide affects T cells: inhibition of NF-kappaB activation, cell migration, and modulation of intracellular signaling.

Hecht I, Hershkoviz R, Shivtiel S, Lapidot T, Cohen IR, Lider O, Cahalon L.

J Leukoc Biol. 2004 Jun;75(6):1139-46. Epub 2004 Mar 12.

PMID:
15020655
46.

Fibronectin-associated Fas ligand rapidly induces opposing and time-dependent effects on the activation and apoptosis of T cells.

Zanin-Zhorov A, Hershkoviz R, Hecht I, Cahalon L, Lider O.

J Immunol. 2003 Dec 1;171(11):5882-9.

47.

Heterologous desensitization of T cell functions by CCR5 and CXCR4 ligands: inhibition of cellular signaling, adhesion and chemotaxis.

Hecht I, Cahalon L, Hershkoviz R, Lahat A, Franitza S, Lider O.

Int Immunol. 2003 Jan;15(1):29-38.

PMID:
12502723
48.

Combinatorial signals by inflammatory cytokines and chemokines mediate leukocyte interactions with extracellular matrix.

Vaday GG, Franitza S, Schor H, Hecht I, Brill A, Cahalon L, Hershkoviz R, Lider O.

J Leukoc Biol. 2001 Jun;69(6):885-92. Review.

PMID:
11404372
49.

[Organization of medical and social hospital care of elderly persons in Russia].

Galkin RA, Suslin SA, Hecht IA, Pavlov VV.

Probl Sotsialnoi Gig Zdravookhranenniiai Istor Med. 2000 Sep-Oct;(5):43-6. Russian.

PMID:
11190431
50.

Disaccharides generated from heparan sulphate or heparin modulate chemokine-induced T-cell adhesion to extracellular matrix.

Hershkoviz R, Schor H, Ariel A, Hecht I, Cohen IR, Lider O, Cahalon L.

Immunology. 2000 Jan;99(1):87-93.

Supplemental Content

Support Center